Home › Epidermolysis Bullosa Dystrophica › California
Pag-aaral pangklinika para sa Epidermolysis Bullosa Dystrophica sa California
7 pag-aaral para sa Epidermolysis Bullosa Dystrophica ang naghahanap ng mga kalahok sa mga site sa California.
Mga Lungsod sa California
Opisyal na teksto ng pag-aaral (English)
A Study to Assess the Incidence of Skin Cancers in Patients With Epidermolysis Bullosa Receiving Filsuvez
- Lucile Packard Children's Hospital, Palo Alto
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06423573A Long-Term Safety Follow-up Registry for Patients Who Received Treatment With Prademagene Zamikeracel for Recessive Dystrophic Epidermolysis Bullosa (RDEB) in the Post-Marketing Setting
- Lucile Packard Children's Hospital, Palo Alto
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Hul 14, 2026 · NCT07700966Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa
- Stanford University, Redwood City
Nagre-recruitPhase 1/2
Edad 6 pataas · Lahat ng kasarian · Na-update May 5, 2026 · NCT06834035Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa
- Stanford University School of Medicine, Stanford
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Abr 24, 2026 · NCT01019148A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa
- Mission Dermatology Center, Rancho Santa Margarita
Nagre-recruitPhase 3
6 Months · Lahat ng kasarian · Na-update Mar 12, 2026 · NCT07016750MSC EVs in Dystrophic Epidermolysis Bullosa
- USC /Norris Comprehensive Cancer Center University of Southern California, Los Angeles
Nagre-recruitPhase 1/2
6 Months · Lahat ng kasarian · Na-update Hun 25, 2025 · NCT04173650Long-Term Follow-up Protocol
- Mission Dermatology Center, Rancho Santa Margarita
- Stanford University, Redwood City
Nagre-recruitObservasyonal na pag-aaral
6 Months · Lahat ng kasarian · Na-update Hun 8, 2021 · NCT04917887Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.